KMCSHIL
KMC Speciality Hospitals India share price & financials
- Price
- ₹115.1
- Market cap
- ₹2.3k Cr
- Sector
- Healthcare
Quarterly results
Q1 FY27: revenue up 37.3%, net profit up 112.5% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 56 | 61 | 61 | 67 | 75 +34% | 82 +34% | 82 +34% | 92 +37% |
| EBITDA | 13 | 16 | 15 | 16 | 21 +62% | 25 +56% | 26 +73% | 28 +75% |
| Net profit | 4 | 8 | 5 | 8 | 11 +175% | 14 +75% | 15 +200% | 17 +113% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +110.0% 1Y
1Y: ₹65.95 on 10 Sept 2025 → ₹138.47. High ₹141.65 (21 Aug 2026), low ₹65.95 (10 Sept 2025).
Financials, as filed
Revenue grew 31.5% a year over 2 years, FY24 to FY26. Operating margin widened to 28.8%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹177 Cr | ₹231 Cr | ₹306 Cr |
| Operating profit | ₹47 Cr | ₹57 Cr | ₹88 Cr |
| Operating margin | 26.6% | 24.7% | 28.8% |
| Interest | ₹0 Cr | ₹9 Cr | ₹8 Cr |
| Depreciation | ₹9 Cr | ₹19 Cr | ₹21 Cr |
| Net profit | ₹30 Cr | ₹23 Cr | ₹48 Cr |
| Net margin | 16.9% | 10.0% | 15.7% |
| Cash from operations | ₹38 Cr | ₹58 Cr | ₹79 Cr |
| Free cash flow | ₹-37 Cr | ₹-6 Cr | ₹63 Cr |
| ROCE | 22.0% | 17.0% | 26.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
| Reserves | ₹47 Cr | ₹70 Cr | ₹97 Cr | ₹127 Cr | ₹166 Cr | ₹194 Cr |
| Borrowings | ₹29 Cr | ₹29 Cr | ₹50 Cr | ₹82 Cr | ₹86 Cr | ₹84 Cr |
| Other liabilities | ₹13 Cr | ₹13 Cr | ₹18 Cr | ₹38 Cr | ₹31 Cr | ₹38 Cr |
| Total liabilities | ₹105 Cr | ₹129 Cr | ₹182 Cr | ₹264 Cr | ₹300 Cr | ₹332 Cr |
| Fixed assets | ₹74 Cr | ₹75 Cr | ₹84 Cr | ₹206 Cr | ₹245 Cr | ₹248 Cr |
| Capital work in progress | ₹2 Cr | ₹6 Cr | ₹34 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹29 Cr | ₹48 Cr | ₹63 Cr | ₹57 Cr | ₹55 Cr | ₹84 Cr |
| Total assets | ₹105 Cr | ₹129 Cr | ₹182 Cr | ₹264 Cr | ₹300 Cr | ₹332 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
The ownership split has held steady since Jun 2025. The shareholder count grew 1% to 88,487.
- Promoters
- 75.0%
- FIIs
- 0.0%
- Public
- 25.0%
Since Jun 2025
- FIIs +0.02 pp
- Public −0.02 pp
- Promoters 0.00 pp
How it drifted, 12 quarters
Ownership split by quarter, oldest first. Sep '23: Promoters 75.0%, Public 25.0%.Dec '23: Promoters 75.0%, Public 25.0%.Mar '24: Promoters 75.0%, Public 25.0%.Jun '24: Promoters 75.0%, Public 25.0%.Sep '24: Promoters 75.0%, Public 25.0%.Dec '24: Promoters 75.0%, Public 25.0%.Mar '25: Promoters 75.0%, FIIs 0.0%, Public 25.0%.Jun '25: Promoters 75.0%, Public 25.0%.Sep '25: Promoters 75.0%, Public 25.0%.Dec '25: Promoters 75.0%, Public 25.0%.Mar '26: Promoters 75.0%, Public 25.0%.Jun '26: Promoters 75.0%, FIIs 0.0%, Public 25.0%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Sri Kauvery Medical Care (India) Limited newly disclosed 75.00% held
- Tn Apex Skill Development Centre For Healthcare newly disclosed 0.00% held
- Yashomati Hospitals Private Limited newly disclosed 0.00% held
- Curtis Drug Point Private Limited newly disclosed 0.00% held
- Healthcare Capital Private Limited newly disclosed 0.00% held
The same filing shows 0 holders trimming and 1 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of KMC Speciality Hospitals India Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Sri Kauvery Medical Care (India) Limited | 75.00% | newly disclosed |
| D Chitra | 1.36% | unchanged |
| Anitha S | 1.13% | unchanged |
| Tn Apex Skill Development Centre For Healthcare | 0.00% | newly disclosed |
| Yashomati Hospitals Private Limited | 0.00% | newly disclosed |
| Curtis Drug Point Private Limited | 0.00% | newly disclosed |
| Healthcare Capital Private Limited | 0.00% | newly disclosed |
| Sri Kauvery Medical Care (India)Limited | — | off the list |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
FairTo justify its price of ₹138, this stock must grow earnings at 26% every year for 7 years. Our analysis caps realistic growth at ~24%. At that growth it is worth ₹126 — downside of 9%.
- Growth the price implies
- 25.9% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 26.5% a year
- net profit, FY24–FY26 · EPS 24.0%
- The gap
- 0.0 pp
- -9% downside if it only repeats history
Learn to analyse KMC Speciality Hospitals India Limited
Guides on how to read this kind of business and the numbers that matter.